New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...

To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

Tirzepatide treatment was associated with improved insulin sensitivity and β-cell function regardless of weight loss among patients with obesity.

Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Scholar Rock Holding Corporation (NASDAQ:SRRK) reported positive topline results from its ...

The manufacturers of a new weight-loss drug recently rolled out by the NHS are upping their prices by 170%. Eli Lilly is ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

ASC47 is an adipose-targeted, once-monthly subcutaneously (SQ) injected thyroid hormone receptor beta (THRβ) selective small ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

Obesity is a worldwide problem that is increasing. It also is associated with ocular problems. A recent study found that in ...